Tetragenetics: Imbrium TetraGenetics announce research collaboration and license option to develop biologic therapeutics for pain

Imbrium will leverage TetraGenetics proprietary TetraExpress system to advance monoclonal antibodies that target specific ion channels that are scientifically important in the modulation of pain sensation. The goal The post Imbrium TetraGenetics announce r...